Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EUS Guided Celiac Plexus Block for Chronic Pancreatitis
NCT02399800Terminated
- Sponsor
- University of Southern California
- Start
- Dec 2014
- Primary completion
- Feb 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, single-blind trial of triamcinolone and bupivacaine in chronic pancreatitis (CP) (2 arms), sponsored by University of Southern California. Primary endpoint: Long Term Change in Pain Scores at 24 weeks. Started Dec 2014; status: terminated.
02
Drugs
triamcinolonebupivacaine
03
Conditions
chronic pancreatitis (CP)
Beyond the preview
Go deeper on NCT02399800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02399800.